Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six weeks ago when a study was released showing the medicine failed to prevent heart attacks. The firm told analysts on a conference call this morning the price of Niaspan was raised earlier this year, offsetting the decline in prescriptions.